Veterinary Stents Market Size & Growth Forecast 2026–2035, By Segments (Material, Animal, Product, Application, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
Veterinary Stents Market size was around USD 50.52 Million in 2025 and is slated to grow at a 6.9% CAGR from 2026 to 2035, surpassing USD 98.46 Million by 2035. The industry revenue for 2026 is calculated at USD 53.57 million.
Get more details on this report
Request Free Sample ReportVeterinary Stents Market Intelligence Snapshot
Regional Market Dynamics
- North America leads the market through established companion animal care, advanced veterinary procedures, trained specialists, and referral centers that support consistent demand for interventional stent treatments.
- Asia Pacific is forecast to grow at a 7.8% CAGR as veterinary clinics expand diagnostic capabilities, adopt advanced treatments, and strengthen referral-based care across urban animal healthcare networks.
Segment Momentum
- Nitinol leads with 58.59% share due to its flexibility, shape memory properties, and reliable performance in varied anatomies, making it widely preferred for stable and familiar clinical stent deployment.
- Dogs are both the largest and fastest-growing segment with 61.96% share, driven by higher diagnosis rates, procedural familiarity, and increasing adoption of stent-based treatments for common canine conditions.
Market Expansion Drivers
- Advancements in biodegradable and customizable stents expanding minimally invasive veterinary treatment options.
- Increasing clinical validation of veterinary stents improving adoption for respiratory disorder management.
- Growing pet healthcare expenditure supporting demand for advanced interventional veterinary procedures.
Leading Market Participants
Global Market Forecast Snapshot
Market Outlook
Top players in the veterinary stents market include Infiniti Medical (United States), M.I. Tech Co., Ltd. (South Korea), TaeWoong Medical USA Inc. (United States), Create Medic Co., Ltd. (Japan), Dextronix Animal Health (United States), Jorgensen Laboratories, Inc. (United States), VetStent LLC (United States), B. Braun VetCare GmbH (Germany).Regional and Segment Outlook
North AmericaMarket Growth Drivers and Industry Trends
Advances in biodegradable materials and patient-specific stent design are broadening the range of cases that can be treated through interventional care rather than open surgery, driving demand for the veterinary stents market. In practice, veterinarians are more willing to recommend stenting when device flexibility, sizing accuracy, and degradation profiles better match animal anatomy and the expected course of treatment, especially in cases where permanent implants create follow-up concerns. This is supporting market development by making stent placement a more practical option for complex airway, urinary, and gastrointestinal obstructions, while also encouraging referral centers to expand minimally invasive treatment capabilities.
Increasing clinical validation of veterinary stents improving adoption for respiratory disorder management
As published case outcomes, specialist experience, and procedural protocols become more established, treatment decisions around airway collapse and other respiratory disorders are shifting toward earlier interventional use, increasing market penetration for the veterinary stents market. Clinical validation reduces hesitation among veterinarians and pet owners because it improves confidence in patient selection, procedural safety, and expected symptom relief, which directly influences referral patterns to specialty hospitals. This evidence base also supports more standardized respiratory stenting pathways, reinforcing market demand where conservative management alone often delivers limited long-term control.
Growing pet healthcare expenditure supporting demand for advanced interventional veterinary procedures
Rising spending on companion animal care is changing the treatment threshold for serious but manageable conditions, contributing to market size growth in the veterinary stents market. When owners are more prepared to fund specialist diagnostics, imaging, and intervention-based care, veterinary providers can recommend stent placement for obstructive or respiratory conditions that might previously have been managed palliatively or left untreated. That shift supports market expansion by increasing acceptance of higher-value procedures at referral hospitals and specialty clinics, where stenting is positioned as part of a broader move toward advanced veterinary therapeutics.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Advancements in biodegradable and customizable stents expanding minimally invasive veterinary treatment options | 2.10% | High | North America, Europe | Medium | Mid Term |
| Increasing clinical validation of veterinary stents improving adoption for respiratory disorder management | 1.80% | High | North America, Asia Pacific | High | Near Term |
| Growing pet healthcare expenditure supporting demand for advanced interventional veterinary procedures | 1.50% | Moderate | North America, Europe, Asia Pacific | Emerging | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America held the largest regional share of the veterinary stents market in 2025, supported by a well-established companion animal care ecosystem, broad access to advanced veterinary procedures, and stronger uptake of interventional treatment options in specialty practices. Leadership in the region is sustained by the practical availability of trained veterinary specialists and referral centers that can diagnose and treat complex airway, urinary, and vascular conditions requiring stent placement. This translates into more consistent procedural volumes, earlier case identification, and greater use of higher-value treatment pathways in everyday clinical practice.
Asia Pacific is projected to expand at a 7.8% CAGR over the forecast period, with growth in the veterinary stents market being propelled by rising access to modern veterinary services and increasing adoption of advanced treatment approaches across urban animal care networks. As more clinics and hospitals invest in diagnostic capabilities and referral-based care, veterinarians are better positioned to manage conditions that previously went untreated or were handled conservatively. The region’s momentum is closely tied to this shift toward more intervention-oriented care, which is steadily widening the addressable patient base for stent procedures.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Clinical IntegrationGermany emphasizes clinically validated veterinary interventions supported by well-established animal healthcare services. Veterinary practices in Germany increasingly incorporate stent-based procedures for complex cardiovascular and urinary conditions, encouraging demand for reliable, high-quality implant solutions.
France 🇫🇷
Referral Care FocusFrance supports veterinary stent adoption through an expanding network of referral clinics handling complex animal health cases. Veterinary professionals in France increasingly seek durable implant technologies that enhance procedural efficiency and long-term patient management.
Italy 🇮🇹
Clinical Practice ModernizationItaly continues to modernize veterinary clinical services with greater adoption of advanced surgical and interventional techniques. The veterinary stents market benefits from rising awareness of minimally invasive treatment options among veterinary specialists treating companion animals.
Japan 🇯🇵
Companion Care InnovationJapan's veterinary stents market is influenced by strong demand for advanced treatment options for aging companion animals. Veterinary providers continue to expand minimally invasive capabilities, creating opportunities for specialized stent products tailored to small animal clinical practice.
South Korea 🇰🇷
Specialty Veterinary ExpansionSouth Korea is strengthening access to advanced veterinary diagnostics and interventional procedures through expanding specialty animal hospitals. The country's veterinary stents market reflects increasing interest in minimally invasive therapies that improve treatment outcomes for companion animals.
United States 🇺🇸
Advanced Veterinary AdoptionThe U.S. veterinary stents market benefits from widespread availability of specialty veterinary hospitals and increasing use of minimally invasive procedures. Growing collaboration between veterinary specialists and device manufacturers supports broader adoption of advanced stent technologies across companion animal care.
Segment Leadership and Growth Trends
Veterinary Stents Market Share (%), Material, 2025
Go beyond the chart, access full insights & data tables
Request Free Sample ReportWithin the veterinary stents market, Nitinol held the leading position in 2025 with a 58.59% share, backed by its established use in stent applications that require flexibility, shape memory, and reliable deployment in varied animal anatomies. its position is underpinned by the practical preference for materials that can maintain lumen support under dynamic physiological conditions while also offering clinicians familiarity in procedural handling. In the veterinary stents market, this combination of functional reliability and routine clinical acceptance keeps Nitinol ahead of alternative material options.
Biodegradable Polymer is emerging as the fastest-growing material segment in the veterinary stents market as treatment approaches increasingly favor temporary support solutions that reduce the long-term presence of foreign material in the body. Its momentum is being encouraged by the practical appeal of stents designed to provide structural benefit during healing and then gradually degrade, which aligns well with cases where permanent implantation may be less desirable. Compared with conventional materials, Biodegradable Polymer is experiencing stronger uptake because it responds more directly to evolving procedural preferences centered on reducing follow-up intervention needs.
Animal Segment Analysis: Dogs (Largest & Fastest-Growing Segment)
Dogs accounted for the leading position in the veterinary stents market in 2025 with a 61.96% share, and the same segment is also showing the strongest growth momentum. This dual position is backed by the high volume of canine clinical care in veterinary practice, where stent procedures are more routinely considered for managing airway, urinary, and vascular conditions. In the veterinary stents market, the Dogs segment continues to expand because treatment adoption, diagnosis rates, and procedural familiarity are all more developed in canine care than in other animal categories, allowing demand to build on an already established clinical base.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Material | Nitinol, Biodegradable Polymer | Nitinol | Biodegradable Polymer |
| Animal | Dogs, Cats, Others | Dogs | Dogs |
| Product | Airway Stents, Urethral Stents, Vascular Stents, Others | Airway Stents | Vascular Stents |
| Application | Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions, Others | Airway Collapse | Vascular Obstructions |
| End-use | Veterinary Hospitals & Clinics, Other End-Uses | Veterinary Hospitals & Clinics | Veterinary Hospitals & Clinics |
Competitive Landscape and Market Positioning
1. Infiniti Medical (United States)
2. M.I. Tech Co. Ltd. (South Korea)
3. TaeWoong Medical USA Inc. (United States)
4. Create Medic Co. Ltd. (Japan)
5. Dextronix Animal Health (United States)
6. Jorgensen Laboratories Inc. (United States)
7. VetStent LLC (United States)
8. B. Braun VetCare GmbH (Germany)
The veterinary stents market is witnessing rising innovation in minimally invasive treatment devices designed to improve outcomes in animal cardiovascular and airway procedures. Market participants are focusing on advanced biomaterials, flexible stent structures, and precision deployment technologies to strengthen clinical performance. Collaborative development strategies and growing specialization in veterinary care are also contributing to market expansion.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Infiniti Medical | Oct-24 | Infiniti Medical expanded its "Vet Stent Cava" portfolio with the introduction of 28 mm and 30 mm diameter variants. This strategic product line extension allows for the treatment of a broader range of patients, particularly those suffering from intrahepatic portosystemic shunts, strengthening the company's competitive position in the specialized veterinary interventional device market. |
| Linnaeus Veterinary Limited | Nov-24 | Cardiologists from Linnaeus-owned centers collaborated with The British Veterinary Clinic in the UAE to perform the region's first interventional cardiology procedures on dogs, including pulmonary stenting and balloon valvuloplasty. This initiative marks a significant geographic expansion of advanced minimally invasive veterinary care, driving future demand for specialized stenting solutions in the Middle East region. |
| Infiniti Medical | Dec-23 | Neuromed, a division of Infiniti Medical, provided advanced surgical support for a complex orthopedic case involving a custom antibiotic-infused bone graft. While focused on spinal surgery, the project underscores the integration of multidisciplinary surgical expertise and the increasing reliance on advanced medical devices to improve clinical outcomes for complex, high-acuity veterinary conditions. |
| UW Veterinary Care | Mar-23 | UW Veterinary Care performed a pioneering transpulmonic stent procedure on a canine patient, utilizing techniques previously limited to human medicine. This procedure significantly improved blood flow and patient recovery, demonstrating the application of advanced human-derived vascular technologies in veterinary medicine and the potential for these devices to become a standard of care for severe congenital heart defects in animals. |
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
Veterinary Stents Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| No segment data available. | |
Veterinary Stents Market — report.custom
| Custom Chapter | Custom Details | ||
|---|---|---|---|
| No custom TOC data available. | |||
Need a different cut of the data?
Request Custom ResearchHow much revenue does the veterinary stents market generate?
What is the projected value of the veterinary stents industry by 2035?
How are advancements in biodegradable and customizable stent technologies influencing veterinary treatment adoption?
Why is increasing clinical validation accelerating adoption of veterinary stents in respiratory disorder management?
Why does Nitinol dominate the veterinary stents market?
Why are Dogs driving growth in the veterinary stents market?
Why does North America dominate the veterinary stents market?
What is fueling veterinary stents market growth in Asia Pacific?
What are the prominent companies operating in the veterinary stents landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization